氟康唑类似物的研究进展

氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。...

Full description

Saved in:
Bibliographic Details
Published in药学实践杂志 Vol. 34; no. 2; pp. 110 - 113
Main Author 许克寒 黄蕾 吴俊琪 戚麟 金永生 俞世冲
Format Journal Article
LanguageChinese
Published 第二军医大学药学院有机化学教研室,上海,200433 2016
Subjects
Online AccessGet full text
ISSN1006-0111
DOI10.3969/j.issn.1006-0111.2016.02.004

Cover

Abstract 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。
AbstractList 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。
R916%R978.5; 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物.随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题.通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索.
Abstract_FL Fluconazole,the third generation of triazole-antifungal drug,becomes the first choice in the treatment of fun-gal infection due to its broad antifungal spectrum,good water solubility and low toxicity.With an increasingly drug-resistant strain,developing new fluconazole derivatives is becoming an attractive topic.This review mainly indicates that people can get new fluconazole derivatives used by clinic through structural modification of fluconazole,which will give clues for advanced re-search.
Author 许克寒 黄蕾 吴俊琪 戚麟 金永生 俞世冲
AuthorAffiliation 第二军医大学药学院有机化学教研室,上海200433
AuthorAffiliation_xml – name: 第二军医大学药学院有机化学教研室,上海,200433
Author_FL XU Kehan
WU Junqi
QI Lin
JIN Yongsheng
YU Shichong
HUANG Lei
Author_FL_xml – sequence: 1
  fullname: XU Kehan
– sequence: 2
  fullname: HUANG Lei
– sequence: 3
  fullname: WU Junqi
– sequence: 4
  fullname: QI Lin
– sequence: 5
  fullname: JIN Yongsheng
– sequence: 6
  fullname: YU Shichong
Author_xml – sequence: 1
  fullname: 许克寒 黄蕾 吴俊琪 戚麟 金永生 俞世冲
BookMark eNo9j09Lw0AUxPdQwVr7IRTBU9b38rKb7FGK_6DgpfewCZuaoBtNEG3PXjwK7UUPeu3NXhS04Jcxxo9hpOJhGBh-zDBrrGVzaxjbQuCkpNrJeFqWliOAdAARuQsoObgcwGux9n--yrplmUYgkHwhMGizja_nx-rttZrc1fP3z8Wivp3V9zf106SevXx_PFTz6TpbSfRpabp_3mGD_b1B79DpHx8c9Xb7TiyU5yjfqMCQMjH5FMVGCjCqkSQQlMSKfA2eJpm4GBmDwlWUIAFq6XpEQlCHbS9rr7RNtB2GWX5Z2GYwHF2X2Xj8-wjc5k9Dbi7J-CS3w4u0Yc-L9EwXo1DKgJpCH-kHwgxa5Q
ClassificationCodes R916%R978.5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1006-0111.2016.02.004
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Research progress of fluconazole derivatives
DocumentTitle_FL Research progress of fluconazole derivatives
EndPage 113
ExternalDocumentID yxsjzz201602004
668362471
GrantInformation_xml – fundername: 第二军医大学药学院药学实验中心孵化基地重点课题; 本科学员创新实践能力孵化基地项目
  funderid: 第二军医大学药学院药学实验中心孵化基地重点课题; (2015YJ06)
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
ID FETCH-LOGICAL-c594-97e98e39ec373bce650e950e63053fc937a04a36f21bee15293f1301a62433553
ISSN 1006-0111
IngestDate Thu May 29 04:07:36 EDT 2025
Wed Feb 14 10:20:23 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords synthesis
合成
fluconazole
antifungal agents
结构修饰
氟康唑
抗真菌药
structural modification
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c594-97e98e39ec373bce650e950e63053fc937a04a36f21bee15293f1301a62433553
Notes 31-1685/R
fluconazole; antifungal agents; structural modification; synthesis
XU Kehan;HUANG Lei;WU Junqi;QI Lin;JIN Yongsheng;YU Shichong;Department of Organic Chemistry,School of Pharmacy,Second Military Medical University; Shanghai 200433, China
Fluconazole,the third generation of triazole-antifungal drug,becomes the first choice in the treatment of fungal infection due to its broad antifungal spectrum,good water solubility and low toxicity.With an increasingly drug-resistant strain,developing new fluconazole derivatives is becoming an attractive topic.This review mainly indicates that people can get new fluconazole derivatives used by clinic through structural modification of fluconazole,which will give clues for advanced research.
PageCount 4
ParticipantIDs wanfang_journals_yxsjzz201602004
chongqing_primary_668362471
PublicationCentury 2000
PublicationDate 2016
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – year: 2016
  text: 2016
PublicationDecade 2010
PublicationTitle 药学实践杂志
PublicationTitleAlternate The Journal of Pharmaceutical Practice
PublicationTitle_FL Journal of Pharmaceutical Practice
PublicationYear 2016
Publisher 第二军医大学药学院有机化学教研室,上海,200433
Publisher_xml – name: 第二军医大学药学院有机化学教研室,上海,200433
SSID ssib051375518
ssib006562796
ssib000270657
ssib017477785
ssib050280699
ssib001104385
ssib036440809
Score 2.047686
Snippet 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课...
R916%R978.5; 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物.随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 110
SubjectTerms 合成
抗真菌药
氟康唑
结构修饰
Title 氟康唑类似物的研究进展
URI http://lib.cqvip.com/qk/91926A/201602/668362471.html
https://d.wanfangdata.com.cn/periodical/yxsjzz201602004
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  issn: 1006-0111
  databaseCode: ABDBF
  dateStart: 20160101
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssib050280699
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Nb9Mw1Ko2CXFBIECMASrS3qnqSGInto_xmmriwKlIu1VJ6mxw6IB1EvTMhSPSuMABrruxC0hsEn-GUn4G7zmmzWGaACmNXmznffilfs9fz4xtVNqKYBSXXV1U1EHJw26RxHF3FFhZ5kFJQelotcWjZPuxeLgT77Rap41VS4eTYrOcnruv5H-0immoV9ol-w-aXSDFBIRRv3hHDeP9r3QMWQImAN2HLAaTgpEEaAE6hEyCCcEYyASYLbowRWlINQE6BSUISAMqT4AGk0CmwPRBG4cwhPpkyj_OK-WqHqSOXIpA4oAMdOZeRIoxsaR7oCKHAVEt7BwVwbJGUY7CyxFBZDrqQKaJVWJJIVEwWcdJEoARToA-qNTxHUCadoiIUiQEvZdiBTgMSjrBXZ0QGemqgvIcBuJSUIZ2fCssFzUHPerdmL6FrodAfAvtm3A_Hvqk0ZOu2-PQr5m1_omfZzW4TrSzGkRgc0GA1v0ldUBXsbSWizWMSaLQ-AuKX7AaSXRzVthqanqm35zUDZqTysiM4I1QQehKR41oh9g3lLIReogndBr4Mrpa7GbBl73HOOSS4um5-XzP8yW24QV6cJE4FEhkb3-8-xzdI7dbbVzl492GYzW4yq74HlE7rT_va6w13bvO7v_8_HH27evs6O385PTH2dn8zfH8_ev5p6P58Zdf3z_MTt7dYIN-Ntja7vrTPLplrEVXS6uV5dqWXPKitNgzsBp_CRocXpXoJeeByHlSRWFhLXqVmlfoX4U51jFHp5jfZCvj_bG9xdqBHJWc53EZWSvyYFTgs6X4qKoaSXSX19j6Qrrhszpoy3ChrjXW9vIO_V_5YPjq5cHT6ZQqKKD25faFCNbZZSpZj8PdYSuTF4f2Lnqmk-Ke_wJ-A17HYY8
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%B0%9F%E5%BA%B7%E5%94%91%E7%B1%BB%E4%BC%BC%E7%89%A9%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E8%8D%AF%E5%AD%A6%E5%AE%9E%E8%B7%B5%E6%9D%82%E5%BF%97&rft.au=%E8%AE%B8%E5%85%8B%E5%AF%92+%E9%BB%84%E8%95%BE+%E5%90%B4%E4%BF%8A%E7%90%AA+%E6%88%9A%E9%BA%9F+%E9%87%91%E6%B0%B8%E7%94%9F+%E4%BF%9E%E4%B8%96%E5%86%B2&rft.date=2016&rft.issn=1006-0111&rft.volume=34&rft.issue=2&rft.spage=110&rft.epage=113&rft_id=info:doi/10.3969%2Fj.issn.1006-0111.2016.02.004&rft.externalDocID=668362471
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91926A%2F91926A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fyxsjzz%2Fyxsjzz.jpg